124 related articles for article (PubMed ID: 32116190)
1. Curcumin Sensitizes Cancers Towards TRAIL-induced Apoptosis via Extrinsic and Intrinsic Apoptotic Pathways.
Ngai SC
Curr Drug Targets; 2020; 21(9):849-854. PubMed ID: 32116190
[TBL] [Abstract][Full Text] [Related]
2. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells.
Wahl H; Tan L; Griffith K; Choi M; Liu JR
Gynecol Oncol; 2007 Apr; 105(1):104-12. PubMed ID: 17174384
[TBL] [Abstract][Full Text] [Related]
3. The TRAIL to cancer therapy: Hindrances and potential solutions.
Wong SHM; Kong WY; Fang CM; Loh HS; Chuah LH; Abdullah S; Ngai SC
Crit Rev Oncol Hematol; 2019 Nov; 143():81-94. PubMed ID: 31561055
[TBL] [Abstract][Full Text] [Related]
4. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.
Deeb D; Jiang H; Gao X; Hafner MS; Wong H; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
Mol Cancer Ther; 2004 Jul; 3(7):803-12. PubMed ID: 15252141
[TBL] [Abstract][Full Text] [Related]
5. TRAIL and curcumin codelivery nanoparticles enhance TRAIL-induced apoptosis through upregulation of death receptors.
Yang X; Li Z; Wu Q; Chen S; Yi C; Gong C
Drug Deliv; 2017 Nov; 24(1):1526-1536. PubMed ID: 28994313
[TBL] [Abstract][Full Text] [Related]
6. Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1-6-heptadine-3,5-dione; C21H20O6] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway.
Deeb D; Jiang H; Gao X; Al-Holou S; Danyluk AL; Dulchavsky SA; Gautam SC
J Pharmacol Exp Ther; 2007 May; 321(2):616-25. PubMed ID: 17289836
[TBL] [Abstract][Full Text] [Related]
7. A novel, soluble compound, C25, sensitizes to TRAIL-induced apoptosis through upregulation of DR5 expression.
James MA; Seibel WL; Kupert E; Hu XX; Potharla VY; Anderson MW
Anticancer Drugs; 2015 Jun; 26(5):518-30. PubMed ID: 25646742
[TBL] [Abstract][Full Text] [Related]
8. Simultaneously targeting bcl-2 and Akt pathways sensitizes nasopharyngeal carcinoma to tumor necrosis factor-related apoptosis-inducing ligand.
Li SS; Tang QL; Wang SH; Wang S; Yang XM
Cancer Biother Radiopharm; 2012 Feb; 27(1):88-95. PubMed ID: 21936689
[TBL] [Abstract][Full Text] [Related]
9. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
[TBL] [Abstract][Full Text] [Related]
10. The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL‑induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells.
Nathwani SM; Greene LM; Butini S; Campiani G; Williams DC; Samali A; Szegezdi E; Zisterer DM
Int J Oncol; 2016 Jul; 49(1):74-88. PubMed ID: 27176505
[TBL] [Abstract][Full Text] [Related]
11. Gambogic acid sensitizes breast cancer cells to TRAIL-induced apoptosis by promoting the crosstalk of extrinsic and intrinsic apoptotic signalings.
Wang S; Xu Y; Li C; Tao H; Wang A; Sun C; Zhong Z; Wu X; Li P; Wang Y
Food Chem Toxicol; 2018 Sep; 119():334-341. PubMed ID: 29458160
[TBL] [Abstract][Full Text] [Related]
12. Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL).
Leahomschi S; Molinsky J; Klanova M; Andera L; Peterka M; Gasova Z; Klener P; Trneny M; Necas E; Simonova T; Zivny J; Klener P
Neoplasma; 2013; 60(2):223-31. PubMed ID: 23259793
[TBL] [Abstract][Full Text] [Related]
13. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.
Wang G; Zhan Y; Wang H; Li W
Cancer Chemother Pharmacol; 2012 Mar; 69(3):799-805. PubMed ID: 22037880
[TBL] [Abstract][Full Text] [Related]
14. IFN‑β sensitizes TRAIL‑induced apoptosis by upregulation of death receptor 5 in malignant glioma cells.
Yoshimura S; Sano E; Hanashima Y; Yamamuro S; Sumi K; Ueda T; Nakayama T; Hara H; Yoshino A; Katayama Y
Oncol Rep; 2019 Dec; 42(6):2635-2643. PubMed ID: 31638255
[TBL] [Abstract][Full Text] [Related]
15. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).
Jung EM; Lim JH; Lee TJ; Park JW; Choi KS; Kwon TK
Carcinogenesis; 2005 Nov; 26(11):1905-13. PubMed ID: 15987718
[TBL] [Abstract][Full Text] [Related]
16. Targeting TRAIL towards the clinic.
Mahalingam D; Oldenhuis CN; Szegezdi E; Giles FJ; de Vries EG; de Jong S; Nawrocki ST
Curr Drug Targets; 2011 Dec; 12(14):2079-90. PubMed ID: 21777191
[TBL] [Abstract][Full Text] [Related]
17. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation.
Jung EM; Park JW; Choi KS; Park JW; Lee HI; Lee KS; Kwon TK
Carcinogenesis; 2006 Oct; 27(10):2008-17. PubMed ID: 16613838
[TBL] [Abstract][Full Text] [Related]
18. Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.
Ryu BJ; Hwang MK; Park M; Lee K; Kim SH
Bioorg Med Chem Lett; 2012 Jun; 22(12):3862-5. PubMed ID: 22622069
[TBL] [Abstract][Full Text] [Related]
19. Linarin sensitizes tumor necrosis factor-related apoptosis (TRAIL)-induced ligand-triggered apoptosis in human glioma cells and in xenograft nude mice.
Xu ZF; Sun XK; Lan Y; Han C; Zhang YD; Chen G
Biomed Pharmacother; 2017 Nov; 95():1607-1618. PubMed ID: 28950661
[TBL] [Abstract][Full Text] [Related]
20. Bio-active Natural Products with TRAIL-Resistance Overcoming Activity.
Ahmed F; Ishibashi M
Chem Pharm Bull (Tokyo); 2016; 64(2):119-27. PubMed ID: 26833440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]